期刊文献+

不同来源血清或血浆培养条件下的树突状细胞表型和功能的比较 被引量:8

Comparison of phenotype and functions of dendritic cells in culture medium supplemented with different serum or plasma
下载PDF
导出
摘要 目的:比较在添加100 mL/L胎牛血清(FBS)、20mL/L人AB血清和10 mL/L供者自体血浆3种不同培养条件下树突状细胞(DC)的表型和功能,为临床应用DC找到安全且有效的培养方法。方法:将外周血单个核细胞(PBMCs)分别在添加100 mL/L FBS,20 mL/L人AB血清,10 mL/L供者自体血浆培养条件下诱导成DC,在培养的第8天,利用流式细胞术(FCM)检测3种培养条件下DC的得率、纯度、表型和抗原捕获能力;用MTT的方法检测DC刺激同种异体淋巴细胞增殖的能力。结果:在DC集落数量、DC得率、DC纯度、抗原捕获能力和刺激淋巴细胞增殖的能力上,100 mL/L FBS培养组优于20 mL/L AB血清和10 mL/L自体血浆组,3组之间DC得率差异比较具有统计学的意义(P<0.05),而其他比较都无统计学的意义(P>0.05)。结论:利用供者自体血浆培养DC是一种安全有效的培养方法,符合细胞治疗规范,可替代异种血清或同种异体血清,成为临床级别DC培养的选择。 AIM: To find a safe and effective method of culturing dendritic cells (DCs) for clinical application by comparing the phenotype and functions of DCs in different culture mediums which are supplemented with 100 ml_/L fetal bovine serum ( FBS), 20 mL/L human AB serum and 10 mL/L autologous plasma. METHODS: Peripheral blood mononuclear cells (PBMCs) were induced to DCs in 100 mL/L FBS, 20 mL/L human AB serum, and 10 mL/L autol- ogous plasma, respectively. On day 8, the purity, pheno- type and antigen uptake capability of DCs were examined by flow cytometry. The mixed lymphocyte reaction (MLR) was detected by MTr assay. RESULTS: Focused on DC aggre- gates, DC yield, DC purity, antigen uptake capability and ability of stimulating lymphocyte proliferation, the experiments showed that those of 100 mL/L FBS culture group were bet- ter than those of 20 mL/L human AB serum and 10 mL/L autologous plasma culture groups. There was no significant difference among these three culture groups (P 〉 0.05) except DC yield ( P 〈 0.05 ). CONCLUSION: Autologous plasma is the best choice for DC cultivation among these three culture ways. It is a safe and efficient way for culturing DCs for clinical purpose.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第6期561-563,567,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 湖南省科技厅产学研结合创新平台建设项目(2010XK6009) 中南大学研究生学位论文创新基金 优博扶植项目(2340-7433001142)
关键词 血清 血浆 树突状细胞 表型 功能 serum plasma dendritic cell phenotype function
  • 相关文献

参考文献9

  • 1Banchereau J, Steinman RM. Dendritic cells and the control of immu- nity[ J ]. Nature, 1998, 392 (6673) : 245 - 252.
  • 2Chang AE, Redman BG, Whitfield JR, et al. A phase I trial of :umor lysate-pulsed dendritic cells in the treatment of advanced cancer [[J]. Clin Cancer Res, 2002, 8(4) : 1021 -1032.
  • 3Rahma OE, Ashtar E, Czystowska M, et al. A gynecologic oncology group phase Ⅱ trial of two p53 peptide vaccine approaches: subcuta- neous injection and intravenous pulsed dendritic cells in high recur- rence risk ovarian cancer patients [ J ]. Cancer Immunol Immunother, 2012, 61 (3) : 373 -384.
  • 4李若冰,陈红松,费然,王松霞,范春蕾,魏来,王宇.用含有特定细胞因子的无血清培养基培养慢性乙型肝炎病人的树突状细胞[J].免疫学杂志,2002,18(6):459-462. 被引量:2
  • 5Buchler T, Hajek R, Bourkova L, et al. Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combi- nations [ J ]. Vaccine, 2003, 21 (9-10) : 877 - 882.
  • 6Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood an improved method with special regard to clini- cal applicability[J]. J Immunol Methods, 1996, 196(2) : 137 - 151.
  • 7Seager Danciger J, Lutz M, Hama S, et al. Method for large scale iso- lation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation[J]. J Immunol Methods, 2004, 288(1-2) : 123 -134.
  • 8Nunez R. Assessment of surface markers and functionality of dendritic cells (DCs) [ J]. Curr Protoc Cytom, 2001, chapter 9 : Unit 9.17.
  • 9周清,吴一龙,郭爱林,王坤,徐崇锐,杨学宁.无血清专用培养基体外快速培养临床级树突状细胞的实验探讨[J].中国肿瘤临床,2006,33(11):605-607. 被引量:5

二级参考文献12

  • 1王坤,吴一龙,周清,林嘉颖,徐崇锐,杨学宁.临床级树突状细胞的分离和培养[J].肿瘤防治研究,2004,31(8):458-460. 被引量:10
  • 2Young LJ, Deane EM. Culture and characterisafion of peripheral blood monocytes and monocyte-derived adherent cells of the tammar wallaby, Macropus eugenii[J]. Immunol Lett, 2005, 96(2):253 - 259
  • 3Buchler T, Hajek R, Bourkova L, et al. Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations[J]. Vaccine, 2003, 21 (9-10):877-882
  • 4Fong L, Engleman EG, Dendritic cells in cancer immunotherapy[J]. J Annu Rev Immunol, 2000, 18(20):245-273
  • 5Peng JC, Thomas R, Nielsen LK, et al. Generation and maturation of dendritic cells for clinical application under serum-free conditions[J]. J Immunother, 2005, 28(6):599-609
  • 6Gullu S, Emral R, Bastemir M, et al, In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis [J]. EurJ Endocrinol, 2005, 153(1):41-48
  • 7Lu W, Arraes LC, Ferreira WT, et al. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection [J]. Nat Med, 2004, 10(12):1359-1365
  • 8Curti A, Isidori A, Ferri E, et al. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy[J]. Leuk Lymphoma, 2004, 45(7):1419-1428
  • 9Mu LJ, Gaudemack G, Saeboe-Larssen S, et al. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines [J]. Scand J Immunol,2003, 58(5):578-586
  • 10姬舒荣.IL-12抗肿瘤免疫治疗及其基因治疗的研究进展[J].国外医学(免疫学分册),2000,23(1):42-46. 被引量:6

共引文献5

同被引文献66

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部